Author: Biotech Express

Key Issues with the “India Bioeconomy Report” • Flawed Research Methodology • Lack of Transparency • Questionable Comparisons • Failure to Account for Economic Factors • Hyped Figures and Misleading Examples • Hyped Job Creation Claims • Overstated Regional Growth • Technological Advancements • Overestimation of Sector Contributions SUBSCRIBE TO READ FULL ARTICLE.

SFI Delhi argues that the proposal lacks transparency and raises significant concerns that could undermine research opportunities and inclusivity in Indian science. SUBSCRIBE TO READ FULL ARTICLE.

Amid concerns over the circumstances of Ayyappan’s death, Venugopal Badaravada, a former governing body member of the Indian Council of Agricultural Research (ICAR), has demanded a court-monitored CBI probe. Badaravada alleged that the incident pointed to “deep-rooted corruption, irregular appointments, and abuse of power within ICAR, ASRB (Agricultural Scientists Recruitment Board), and affiliated institutions.” SUBSCRIBE TO READ FULL NEWS.

A DBT institute dedicated to Animal  Biotechnology Research Message from the Director, NIAB National Institute of Animal Biotechnology (NIAB), an Autonomous Institute of Department of Biotechnology, Ministry of Science and Technology has just completed thirteen years of it’s establishment. The primary man date of this institute is to develop sustainable and globally competitive livestock-based economy for the public and industry through innovative and cutting-edge biotechnologies for research & academic development. NIAB scientists are working in the upstream areas of Biotechnology for improving animal production and health for human welfare. We are committed to driving innovation in animal production, health, disease…

In a groundbreaking webinar conducted by the Federation of Asian Biotech Associations (FABA)-US Chapter, Prof. Ramaiah Muthyala, President and Founder of the Indian Organization for Rare Diseases (IORD) and Research Associate Professor at the University of Minnesota, USA, delivered an inspiring address titled “The Global Burden of Rare Diseases: Issues and Challenges.” The session brought into focus the critical and often overlooked public health crisis posed by rare diseases (RDs) in India, while exploring lessons from global practices, particularly those in the United States. Rare diseases, though individually uncommon, collectively affect a staggering 70 million people in India and over…

Haemophilia is a bleeding disorder that affects millions of people worldwide. According to the Haemophilia and Health Collective of North (HHCN), India has the second-largest population of haemophilia cases in the world, with an estimated 1,36,000 cases affected by haemophilia A. Besides this, India is the first country to classify haemophilia patients as disabled under the Rights of Persons with Disability Act in 2016. Haemophilia is an inherited bleeding disorder that is diagnosed at birth. It is a condition where you’re born with the absence of one clotting factor in your blood, which is required for a blood clot. So,…

Abstract The aquaculture industry is experiencing rapid growth to meet the increasing global demand for seafood. However, this growth has led to increased pressure on traditional aquafeed ingredients, particularly fishmeal and fish oil, which are derived from wild-caught fish. The need for sustainable alternatives has driven research into novel ingredients, with microalgae emerging as promising candidates. This article explores the potential of microalgae as a sustainable aquafeed ingredient, discussing their importance, benefits, challenges, ongoing research, and future directions. Importance of Microalgae in Aquafeed Microalgae are photosynthetic microorganisms that form the base of many aquatic food chains. Their use in aquafeed…

Scientists affiliated to the Department of Biotechnology (DBT) have developed an ‘anti-pesticide’ suit called Kisan Kavach. The suit is intended to protect farm labourers from imbibing the pesticides they spray which are potential neurotoxins and detrimental to health. The price per kit is ₹4,000. The kit retained its potency in a wide temperature range, under UV-light exposure and was protective even after a 150 washes. The inStem scientists have formed a company, Sepio Health Pvt. Ltd. to manufacture the kisan kavach. Farmers who spray insecticide or pesticides usually cover themselves from head to toe with ordinary cloth. This approach,…

The Nobel Assembly at the Karolinska Institute has taken a liking to RNA. The committee has awarded two American biologists the 2024 Nobel Prize in Physiology or Medicine for their discovery of microRNA, the small RNA molecules that regulate genes, one year after the prize went to scientists who conducted foundational work on mRNA vaccines. The laureates are Victor Ambros, Ph.D., and Gary Ruvkun, Ph.D. Ambros is a professor at UMass Chan Medical School, while Ruvkun is a professor at Harvard Medical School. Ambros’ team spent years attempting to identify the nature of lin-4, while Ruvkun’s focused on lin-14. Ambros’…

Biocon’s arm, Biocon Biologics Ltd (BBL), announced today that the US Food and Drug Administration (USFDA) has approved YESINTEK (Ustekinumab-kfce), a biosimilar to the reference product Stelara (Ustekinumab), according to a company filing. YESINTEK, a monoclonal antibody, is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Shreehas Tambe, chief executive officer and managing director of Biocon Biologics, said, “This settlement agreement reflects our commitment and focus on science and innovation. We are pleased that this allows Biocon Biologics to be among the first to offer a reliable, high-quality biosimilar option to patients and healthcare…